Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli

Clinical and Experimental Medicine

Volumn 8, Issue 1, 2008, Pages 37-42

  Luo, Yi Qin ^a   Wang, Liang Hua ^b   Yi, Qui ^b   Jiao, Bing Hua ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biological activity; Fusion expression; Recombinant protein; Tumstatin

Indexed keywords

AMYLOSE; BLOOD CLOTTING FACTOR 10A; LIPOCORTIN 5; MALTOSE BINDING PROTEIN; RECOMBINANT PROTEIN; TUMSTATIN;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BACTERIUM CULTURE; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; DOSE RESPONSE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

ANIMALS; AUTOANTIGENS; CARRIER PROTEINS; CELL LINE; CELL PROLIFERATION; CHICK EMBRYO; COLLAGEN TYPE IV; ENDOTHELIAL CELLS; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC VECTORS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; SOLUBILITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 43449102805     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-008-0154-2     Document Type: Article

References (21)

1. Folkman J (2001) In: Brauwald E (ed) Harrison's textbook of internal medicine, 15th Edn, McGraw-Hill, New York, pp 517-530
2. Hanahan D, Folkman J (2000) The hallmarks of cancer. Cell 100:57-70
3. O'Reilly MS, Holmgren L, Shing Y et al (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328
4. O'Reilly MS, Boehm T, Shing Y et al (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285
5. Kamphaus GD, Colorado PC, Panka DJ et al (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275:1209-1215
6. Colorado PC, Torre A, Kamphaus G et al (2000) Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 60:2520-2526
7. Maeshima Y, Colorado PC, Torre A et al (2000) Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 275:21340-21348
8. Luo YQ, Wang LH, Ma XL et al (2006) Construction, expression, and characterization of a new targeted bifunctional fusion protein: tumstatin45-132-TNF. IUBMB Life 58:647-653
9. Sambrook J, Fritsch EF, Maniatis T (2001) A laboratory manual. Cold Spring Harbor Press, New York, pp 66-87
10. van Engeland M, Nieland LJ, Ramaekers FC et al (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidyl serine exposure. Cytometry 1:1-9
11. Nguyen M, Shing Y, Folkman J (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47:31-40
12. Maeshima Y, Sudhakar A, Lively JC et al (2002) Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295:140-143
13. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
14. Moser TL, Stack MS, Wahl ML et al (2002) The mechanism of action of angiostatin: can you teach an old dog new tricks? Thromb Haemost 87:394-401
15. Mukhopadhyay A (1997) Inclusion bodies and purification of proteins in biologically active forms. Adv Biochem Eng Biotechnol 56:61-109
16. Nagai K, Perutz MF, Poyart C (1985) Oxygen binding properties of human mutant hemoglobins synthesized in Escherichia coli. Proc Natl Acad Sci U S A 82:7252-7255
17. Quinlan RA, Moir RD, Stewart M (1989) Expression in Escherichia coli of fragments of glial fibrillary acidic protein: characterization, assembly properties and paracrystal formation. J Cell Sci 93:71-83
18. Eaton D, Rodriguez H, Vehar GA (1986) Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry 25:505-512
19. Wearne SJ (1990) Factor Xa cleavage of fusion proteins. Elimination of non-specific cleavage by reversible acylation. FEBS Lett 263:23-26
20. Kapust RB, Waugh DS (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 8:1668-1674
21. Fox JD, Kapust RB, Waugh DS (2001) Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins. Protein Sci 10:622-630